Renal effects, including acute kidney injury, have been reported rarely in post-marketing surveillance, typically in the context of severe gastrointestinal adverse effects leading to dehydration
The full step-by-step protocol examples, titration, and printable protocol sheet are planned for a future paid Protocol Playbook module
Warnings For use under medical supervision only
It also boosts VEGF (vascular endothelial growth factor), improving blood flow and nutrient delivery to active follicles
Safety and Open Questions Mechanistic studies have confirmed that 5-Amino-1MQ treatment increases NAD+ levels in adipose tissue and liver, enhances SIRT1 activity, and activates downstream targets including PGC-1 and AMPK
AOD-9604 is not FDA-approved